Optimal Dose, Timing and Ratio of Blood Products in Massive Transfusion: Results from a Systematic Review

Transfusion Medicine Reviews

Volumn 32, Issue 1, 2018, Pages 6-15

  McQuilten, Zoe K ^a   Crighton, Gemma ^a   Brunskill, Susan ^b   Morison, Jessica K ^a   Richter, Tania H ^a   Waters, Neil ^a   Murphy, Michael F ^b   Wood, Erica M ^a  

^a MONASH UNIVERSITY   (Australia)

^b NHS BLOOD AND TRANSPLANT   (United Kingdom)

Author keywords

Cryoprecipitate; Fresh frozen plasma; Hemorrhage; Platelet transfusion; Red blood cell transfusion; Trauma

Indexed keywords

FIBRINOGEN CONCENTRATE; FRESH FROZEN PLASMA; THROMBOCYTE CONCENTRATE; HEMOSTATIC AGENT;

BLEEDING; BLOOD CELL RATIO; BLOOD TRANSFUSION; BURN; ERYTHROCYTE CONCENTRATE; EVIDENCE BASED MEDICINE; FEASIBILITY STUDY; HUMAN; INJURY; INJURY SEVERITY; INTERMETHOD COMPARISON; META ANALYSIS; MORBIDITY; MORTALITY RATE; OPTIMAL DRUG DOSE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; RISK FACTOR; SYSTEMATIC REVIEW; TIME TO TREATMENT; ADULT; BLOOD; BLOOD COMPONENT THERAPY; BLOOD TRANSFUSION REACTION; CHILD; ERYTHROCYTE TRANSFUSION; MORTALITY; PLASMA; PROCEDURES; STATISTICS AND NUMERICAL DATA; THROMBOCYTE TRANSFUSION; TIME FACTOR;

ADULT; BLOOD COMPONENT TRANSFUSION; BLOOD TRANSFUSION; CHILD; ERYTHROCYTE TRANSFUSION; HEMORRHAGE; HEMOSTATICS; HUMANS; PLASMA; PLATELET TRANSFUSION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TIME FACTORS; TRANSFUSION REACTION;

EID: 85028346938     PISSN: 08877963     EISSN: 15329496     Source Type: Journal    
DOI: 10.1016/j.tmrv.2017.06.003     Document Type: Review

References (30)

1. Halmin, M., Chiesa, F., Vasan, S.K., Wikman, A., Norda, R., Rostgaard, K., et al. Epidemiology of massive transfusion: a Binational study from Sweden and Denmark. Crit Care Med 44 (2016), 468–477.
2. Hunt, H., Stanworth, S., Curry, N., Woolley, T., Cooper, C., Ukoumunne, O., et al. Thromboelastography (TEG) and rotational thromboelastometry (ROTEM) for trauma induced coagulopathy in adult trauma patients with bleeding. Cochrane Database Syst Rev, 2, 2015, CD010438.
3. Bhangu, A., Nepogodiev, D., Doughty, H., Bowley, D.M., Meta-analysis of plasma to red blood cell ratios and mortality in massive blood transfusions for trauma. Injury 44 (2013), 1693–1699.
4. Holcomb, J.B., del Junco, D.J., Fox, E.E., Wade, C.E., Cohen, M.J., Schreiber, M.A., et al. The prospective, observational, multicenter, major trauma transfusion (PROMMTT) study: comparative effectiveness of a time-varying treatment with competing risks. JAMA Surg 148 (2013), 127–136.
5. Holcomb, J.B., Zarzabal, L.A., Michalek, J.E., Kozar, R.A., Spinella, P.C., Perkins, J.G., et al. Increased platelet:RBC ratios are associated with improved survival after massive transfusion. J Trauma 71 (2011), S318–S328.
6. Inaba, K., Lustenberger, T., Rhee, P., Holcomb, J.B., Blackbourne, L.H., Shulman, I., et al. The impact of platelet transfusion in massively transfused trauma patients. J Am Coll Surg 211 (2010), 573–579.
7. McQuilten, Z.K., Crighton, G., Engelbrecht, S., Gotmaker, R., Brunskill, S.J., Murphy, M.F., et al. Transfusion interventions in critical bleeding requiring massive transfusion: a systematic review. Transfus Med Rev 29 (2015), 127–137.
8. National Blood Authority (NBA), Patient blood management guidelines module one: Critical bleeding/massive transfusion. 2011, NBA, Canberra Available at: https://www.blood.gov.au/pbm-guidelines (Accessed 22/11/2016).
9. Zatta, A.J., ZK, McQuilten, Mitra, B., Roxby, D.J., Sinha, R., Whitehead, S., et al. Elucidating the clinical characteristics of patients captured using different definitions of massive transfusion. Vox Sang 107 (2014), 60–70.
10. Cochrane handbook for systematic reviews of interventions version 5.1.0, 2011.
11. Aawar, N., Alikhan, R., Bruynseels, D., Cannings-John, R., Collis, R., Dick, J., et al. Fibrinogen concentrate versus placebo for treatment of postpartum haemorrhage: study protocol for a randomised controlled trial. Trials, 16, 2015, 169.
12. Chapman, M.P., Moore, E.E., Chin, T.L., Ghasabyan, A., Chandler, J., Stringham, J., et al. Combat: initial experience with a randomized clinical trial of plasma-based resuscitation in the field for traumatic hemorrhagic shock. Shock 44:Suppl. 1 (2015), 63–70.
13. Cotton, B.A., Podbielski, J., Camp, E., Welch, T., del Junco, D., Bai, Y., et al. A randomized controlled pilot trial of modified whole blood versus component therapy in severely injured patients requiring large volume transfusions. Ann Surg 258 (2013), 527–532 [discussion 32-3].
14. Curry, N., Rourke, C., Davenport, R., Beer, S., Pankhurst, L., Deary, A., et al. Early cryoprecipitate for major haemorrhage in trauma: a randomised controlled feasibility trial. Br J Anaesth 115 (2015), 76–83.
15. Nascimento, B., Callum, J., Tien, H., Rubenfeld, G., Pinto, R., Lin, Y., et al. Effect of a fixed-ratio (1:1:1) transfusion protocol versus laboratory-results-guided transfusion in patients with severe trauma: a randomized feasibility trial. CMAJ 185 (2013), E583–E589.
16. Auckland City Hospital: The effect of upfront Administration of Fibrinogen concentrate on total blood volume loss in obstetric Haemorrhage – A pilot study. In: Australia and New Zealand clinical trial registry [internet]: Sydney (NSW): NHMRC clinical trials Centre, University of Sydney (Australia); identifier ACTRN12614000691640. Available from www.anzctr.org.au/ACTRN12614000691640.aspx (Accessed 22/11/2016).
17. NHS Blood and Transplant (NHSBT), A multi-centre, randomised, double blind, placebo-controlled trial evaluating the effects of early administration of fibrinogen concentrate in adults with major traumatic haemorrhage. ISRCTN67540073. Available at: http://www.isrctn.com/ISRCTN67540073 (Accessed 22/11/2016).
18. Trauma and Acute Critical Care Medical Center, Tokyo Medical and Dental University, Intervention study about the additive infusion of concentrated fibrinogen preparation and the amount of blood transfusion for the massive hemorrhage case. JPRN-UMIN000019027. Available at: https://upload.umin.ac.jp/cgi-open-bin/ctr/ctr.cgi?function=brows&action=brows&type=summary&recptno=R000022000&language=E [Accessed 22/11/2016].
19. Medical University Innsbruck: RETIC Trial: Reversal of Trauma Induced Coagulopathy Using Coagulation Factor Concentrates or Fresh Frozen Plasma. In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US) 2000–2016. 2012 Available from: https://clinicaltrials.gov/ct2/show/NCT01545635. [NLM Identifier: NCT01545635 (Accessed 22/11/2016)].
20. Rigshospitalet, Denmark, Pilot Randomized Trial of Fibrinogen in Trauma Haemorrhage. In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US) 2000–2016. 2015 Available from: https://clinicaltrials.gov/ct2/show/NCT02344069. NLM Identifier: NCT02344069. (Accessed 22/11/2016).
21. Nascimento, B., Callum, J., Tien, H., Peng, H., Rizoli, S., Karanicolas, P., et al. Fibrinogen in the initial resuscitation of severe trauma (FiiRST): a randomized feasibility trial. Br J Anaesth 117 (2016), 775–782.
22. Galganski, L.A., Greenhalgh, D.G., Sen, S., Palmieri, T.L., Randomized comparison of packed red blood cell-to-fresh frozen plasma transfusion ratio of 4: 1 vs 1: 1 during acute massive burn excision. J Burn Care Res 38 (2017), 194–201.
23. Holcomb, J.B., Tilley, B.C., Baraniuk, S., Fox, E.E., Wade, C.E., Podbielski, J.M., et al. Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial. JAMA 313 (2015), 471–482.
24. Queen Mary Univesrity of London, Early cryoprecipitate in major trauma haemorrhage: CRYOSTAT-2. ISCTRN14998314. Available at: https://www.isrctn.com/ISCTRN14998314 [Accessed 17/5/2017].
25. Gold Coast Hospital and Health Service, Fibrinogen Early In Severe Trauma studY (FEISTY). In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US) 2000–2016. 2016 Available from: https://clinicaltrials.gov/ct2/show/NCT02745041. NLM Identifier: NCT02745041. (Accessed 17/5/2017).
26. University Health Network Toronto, FIBrinogen REplenishment in Surgery (FIBRES). In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US) 2000–2016. 2017 Available from: https://clinicaltrials.gov/ct2/show/NCT03037424. NLM Identifier: NCT03037424. (Accessed 17/5/2017).
27. Baraniuk, S., Tilley, B.C., Del Junco, D.J., Fox, E.E., van Belle, G., Wade, C.E., et al. Pragmatic randomized optimal platelet and plasma ratios (PROPPR) trial: design, rationale and implementation. Injury 45 (2014), 1287–1295.
28. Jairath, V., Kahan, B.C., Gray, A., Dore, C.J., Mora, A., James, M.W., et al. Restrictive versus liberal blood transfusion for acute upper gastrointestinal bleeding (TRIGGER): a pragmatic, open-label, cluster randomised feasibility trial. Lancet 386 (2015), 137–144.
29. Collins, P.W., Solomon, C., Sutor, K., Crispin, D., Hochleitner, G., Rizoli, S., et al. Theoretical modelling of fibrinogen supplementation with therapeutic plasma, cryoprecipitate, or fibrinogen concentrate. Br J Anaesth 113 (2014), 585–595.
30. Queen Mary University of London, Implementing Treatment Algorithms for the Correction of Trauma Induced Coagulopathy (iTACTIC). In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US) 2000–2016. 2015 Available from: https://clinicaltrials.gov/ct2/show/NCT02593877. NLM Identifier: NCT02593877.